Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.61 |
| ▸ | CNR2 | P34972 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | DRD1 | P21728 | 1/20 | 0.47 |
| ▸ | DRD4 | P21917 | 1/20 | 0.47 |
| ▸ | DRD5 | P21918 | 1/20 | 0.47 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21034797 | 0.89 | ALOX15 (0.50) | MAPK1ALOX5TSHRCYP2D6DRD2 | |
| SCHEMBL1004694 | 0.88 | NPC1 (0.68) | CNR1CNR2HTTNPC1HPGD | |
| SCHEMBL3617672 | 0.84 | PPARA (0.61) | HTTNPC1HPGDMAPK1RAB9A | |
| SCHEMBL8590804 | 0.84 | PPARA (0.61) | HTTNPC1HPGDMAPK1RAB9A | |
| SCHEMBL10067551 | 0.84 | PPARA (0.61) | HTTNPC1HPGDMAPK1RAB9A | |
| SCHEMBL11554693 | 0.84 | PPARA (0.61) | HTTNPC1HPGDMAPK1RAB9A | |
| Potassium SCHEMBL30435596 | 0.83 | PPARA (0.59) | HTTNPC1HPGDMAPK1RAB9A | |
| SCHEMBL332894 | 0.83 | CNR1 (0.67) | CNR1CNR2ALOX5TSHRCYP3A4 | |
| SCHEMBL8400508 | 0.83 | IGF1R (0.61) | HTTNPC1HPGDMAPK1RAB9A | |
| SCHEMBL10626367 | 0.83 | MAPT (0.65) | HPGDMAPK1NPSR1ALOX5TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021127612-A1 | BIOMASS-BASED PESTICIDES AND METHODS OF MAKING THE SAME | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2021-06-24 | — | — | WO | claimed |
| WO-2014001056-A1 | ANTIMICROBIAL COMPOSITION | UNILEVER N.V. (NL) | 2014-01-03 | — | — | WO | claimed |
| EP-1418892-A1 | SYNERGISTIC MIXED POLOXAMER SYSTEMS FOR THE SOLUBILISATION OF DRUGS | Maelor Pharmaceuticals Limited (GB) | 2004-05-19 | — | — | EP | claimed |
| CN-1488664-A | Vibration damping material composition | 株式会社泰特克斯 | 2004-04-14 | — | — | CN | claimed |
| WO-2003017976-A1 | SYNERGISTIC MIXED POLOXAMER SYSTEMS FOR THE SOLUBILISATION OF DRUGS | MAELOR PHARMACEUTICALS LIMITED (GB) | 2003-03-06 | — | — | WO | claimed |
| US-12421349-B2 | Polyphenylene ether composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-09-23 | — | — | US | disclosed |
| EP-4322927-A1 | NOVEL USE | DSM IP Assets B.V. (NL) | 2024-02-21 | — | — | EP | disclosed |
| CN-117229495-A | Polyphenylene ether, method for producing the same, thermosetting composition, prepreg, and laminate | 旭化成株式会社 | 2023-12-15 | — | — | CN | disclosed |
| EP-4039728-B1 | POLYPHENYLENE ETHER COMPOSITION | ASAHI CHEMICAL IND (JP) | 2023-10-11 | — | — | EP | disclosed |
| CN-112812291-B | Hydrogenated polyphenylene ether and process for producing the same | 旭化成株式会社 | 2023-07-18 | — | — | CN | disclosed |
| US-20230117370-A1 | REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS | OREGON STATE UNIVERSITY (US) | 2023-04-20 | — | — | US | disclosed |
| WO-2022239631-A1 | NOVEL TERMINAL-MODIFIED POLYPHENYLENE ETHER AND TERMINAL-MODIFIED POLYPHENYLENE ETHER COMPOSITION | 旭化成株式会社 | 2022-11-17 | — | — | WO | disclosed |
| WO-2003017976-A1 | SYNERGISTIC MIXED POLOXAMER SYSTEMS FOR THE SOLUBILISATION OF DRUGS | MAELOR PHARMACEUTICALS LIMITED (GB) | 2003-03-06 | — | — | WO | disclosed |
| WO-2001015680-A9 | COMPOSITION FOR TREATMENT OF INFECTIONS OF HUMANS AND ANIMALS | BEEK GLOBAL NINKOV L L C VAN (US) | 2002-09-12 | — | — | WO | disclosed |
| WO-2002058469-A1 | PESTICIDAL COMPOUNDS AND COMPOSITIONS | VAN BEEK, RON (US) | 2002-08-01 | — | — | WO | disclosed |
| EP-1207865-A1 | COMPOSITION FOR TREATMENT OF INFECTIONS OF HUMANS AND ANIMALS | Van Beek Global/Ninkov L.L.C. (US) | 2002-05-29 | — | — | EP | disclosed |
| WO-2001059008-A1 | PETROLEUM ASPHALTS MODIFIED BY LIQUEFIED BIOMASS ADDITIVES | WASTE TECHNOLOGY TRANSFER, INC. (US) | 2001-08-16 | — | — | WO | disclosed |
| US-6258854-B1 | KETONE ETHERS FOR ODORS | GIVAUDAN ROURE ( INTERNATIONAL ) SA (CH) | 2001-07-10 | — | — | US | disclosed |
| WO-2001015680-A1 | COMPOSITION FOR TREATMENT OF INFECTIONS OF HUMANS AND ANIMALS | VAN BEEK GLOBAL/NINKOV L.L.C. (US) | 2001-03-08 | — | — | WO | disclosed |
| WO-2000013690-A1 | EXOCYCLIC-PHOSPHOETHANOLAMINES | CLARION PHARMACEUTICALS, INC. (US) | 2000-03-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230117370-A1 | REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS | CYP2B6, TYR, CYP2D6 | CNR1 1446/4885CNR2 1150/4885HTT 3738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.